文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

脑转移瘤术前分次立体定向放射外科的前瞻性初步研究

Preoperative Fractionated Stereotactic Radiosurgery for Brain Metastases: A Prospective Pilot Study at a Single Institution.
PubMed 文献 · Adv Radiat Oncol · 2025-11-08

这项单中心前瞻性初步研究(原计划为2期方案)评估了可手术脑转移瘤患者接受伽玛刀Icon 3次分次术前立体定向放射外科(SRS)的疗效与安全性。20例入组患者接受24-27 Gy/3次照射后2周内手术,1年局部控制率95%,脑膜播散(LMD)发生率9.6%,未记录到放射性坏死。

要点

  • 术前分次SRS(24-27 Gy/3次)后中位1天手术,1年局部控制率95%。
  • LMD发生率9.6%,随访中未记录放射性坏死,1年无WBRT生存78%。
  • 1年总生存52%,6个月和12个月远处脑失败率均为38%。

核心结论

  • 术前分次SRS似乎安全有效,局部控制率高,LMD和放射性坏死发生率低。

研究设计与样本

  • 单中心前瞻性初步研究,原计划为2期方案,入组20例可手术的脑转移瘤患者,另11例在方案外接受1-3次治疗。
  • 患者接受伽玛刀Icon分次SRS至24-27 Gy/3次,2周内手术,术后每3个月随访MRI至2年。

主要发现

  • 中位年龄64岁(31-81),55%为女性,原发肿瘤主要为非小细胞肺癌、黑色素瘤和食管癌。
  • 中位处方剂量27 Gy(15-27 Gy)/3次(1-3次),术后中位1天(0-11)手术,所有可评估术后MRI均示全切除。
  • 1年局部控制率95%(1例局部失败),6个月和12个月远处脑失败率均为38%,3例(9.6%)发生LMD,1年无WBRT生存78%。
  • 1年总生存52%;Cox回归未发现总生存、局部失败或远处脑失败的预测因素。
  • 2例发生短期毒性:1例2级颅内肿胀和1例与高血压危象相关的5级出血性卒中;随访未记录放射性坏死。

关键数值与推荐

  • 术前SRS处方剂量24-27 Gy分3次,术后2周内手术。
  • 1年局部控制率95%,LMD发生率9.6%,1年无WBRT生存78%。

临床怎么用

  • 对于可手术的脑转移瘤患者,术前分次SRS可能作为减少LMD和放射性坏死、同时维持局部控制的策略。
  • 需关注高血压危象相关出血性卒中等短期毒性风险。

局限性

  • 单中心前瞻性初步研究,样本量小(20例入组),随访时间短(中位9个月)。
  • 部分患者(11例)在方案外治疗,并非全部按3次方案执行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Brain metastases are a common occurrence in patients with advanced malignancy. Treatment ranges from surgical resection, stereotactic radiosurgery (SRS), whole-brain radiation therapy (WBRT), or some combination thereof. Traditionally, SRS has followed surgical resection to help reduce the risk of local recurrence. In recent years, interest has arisen in treating these patients in the preoperative setting to help reduce the risk of leptomeningeal disease (LMD) and radiation necrosis while preserving rates of local control. This prospective pilot study, originally planned as a phase 2 protocol, investigated the use of 3-fraction preoperative SRS on the Gamma Knife (GK) Icon with the goal of examining those outcomes. METHODS AND MATERIALS: Patients who had symptomatic and a limited number of brain metastases amenable to surgical resection were prospectively enrolled in this study. Patients were treated with fractionated SRS on the GK Icon to 24 to 27 Gy in 3 fractions followed by surgical resection within 2 weeks. Postoperative MRIs were obtained to assess the extent of resection. Patients were then followed up with standard-of-care MRIs every 3 months for the first 2 years. Rates of local control, distant brain failure, LMD, and delivery of WBRT were recorded on follow-up. RESULTS: Twenty patients were prospectively enrolled in the trial, and an additional 11 were treated off study using 1 to 3 fractions between April 2021 and June 2024. The median age was 64 (31-81), and 55% were females. Primary malignancies were mainly non-small cell lung cancer, melanoma, and esophageal cancer. The median prescription dose was 27 Gy (15-27 Gy) in 3 (1-3) fractions. Surgery was performed at a median of 1 day post-SRS (0-11). All available postoperative MRIs showed gross total resection. Median follow-up was 9 months. One patient experienced a local failure, yielding a 1-year local control rate of 95%. The rate of distant brain failure at 6 and 12 months was 38% at each time point. Three patients (9.6%) developed LMD in follow-up. Six patients ultimately received WBRT, yielding a 1-year WBRT-free survival of 78%. Overall survival at 1 year was 52%. There were no predictors of overall survival, local failure, or distant brain failure on Cox regression. Two patients experienced short-term toxicity, including grade 2 intracranial swelling and one grade 5 hemorrhagic stroke related to a hypertensive crisis. There was no recorded radionecrosis in follow-up. CONCLUSIONS: Fractionated preoperative SRS appears to be safe and effective with high rates of local control and low rates of LMD and radionecrosis. Results of ongoing phase 3 studies directly comparing preoperative to postoperative SRS will help further define the appropriate sequencing of therapies.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Marwaha A, Shepard MJ, Liang Y, et al. Preoperative Fractionated Stereotactic Radiosurgery for Brain Metastases: A Prospective Pilot Study at a Single Institution. Adv Radiat Oncol. 2025. PMID: 41503286. doi:10.1016/j.adro.2025.101951

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。